Pictet Asset Management (UK)’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-237,437
| Closed | -$16.1M | – | 1124 |
|
|
2019
Q3 | $16.1M | Buy |
237,437
+21,900
| +10% | +$1.49M | 0.03% | 430 |
|
|
2019
Q2 | $12.5M | Buy |
215,537
+52,037
| +32% | +$3.03M | 0.03% | 470 |
|
|
2019
Q1 | $11.5M | Buy |
163,500
+52,700
| +48% | +$3.69M | 0.03% | 493 |
|
|
2018
Q4 | $7.14K | Buy |
110,800
+33,800
| +44% | +$2.18K | 0.02% | 565 |
|
|
2018
Q3 | $5.41M | Sell |
77,000
-9,600
| -11% | -$674K | 0.01% | 703 |
|
|
2018
Q2 | $4.37M | Sell |
86,600
-16,800
| -16% | -$847K | 0.01% | 693 |
|
|
2018
Q1 | $3.24M | Buy |
103,400
+13,800
| +15% | +$432K | 0.01% | 735 |
|
|
2017
Q4 | $3.06M | Buy |
+89,600
| New | +$3.06M | 0.01% | 750 |
|
|
2015
Q1 | – | Sell |
-79,700
| Closed | -$2.55M | – | 899 |
|
|
2014
Q4 | $2.55M | Sell |
79,700
-2,900
| -4% | -$92.7K | 0.01% | 713 |
|
|
2014
Q3 | $2.34M | Sell |
82,600
-47,400
| -36% | -$1.34M | 0.01% | 709 |
|
|
2014
Q2 | $3.56M | Buy |
130,000
+35,300
| +37% | +$967K | 0.02% | 631 |
|
|
2014
Q1 | $2.49M | Buy |
94,700
+3,400
| +4% | +$89.5K | 0.01% | 703 |
|
|
2013
Q4 | $2.67M | Sell |
91,300
-40,000
| -30% | -$1.17M | 0.01% | 678 |
|
|
2013
Q3 | $4.02M | Sell |
131,300
-57,300
| -30% | -$1.75M | 0.02% | 571 |
|
|
2013
Q2 | $5.98M | Buy |
+188,600
| New | +$5.98M | 0.03% | 440 |
|